Lifeboat Foundation

Continuous automatic sampling during production aims to keep Danish biotechnology at the forefront. The equipment, and the company behind it, are the result of fruitful collaboration between businesses and universities.

Biotech companies can now take samples from their production as often as they wish, untouched by human hands.

This is all thanks to new equipment developed by start-up company Biomatics Technology. Both the company and product were nurtured in the Biopro network, which involves a number of Danish biotech companies and DTU and the University of Copenhagen.

Read more

Underground settings are becoming increasingly relevant to global security and safety. Rising populations and urbanization are requiring military and civilian first responders to perform their duties below ground in human-made tunnels, underground urban spaces, and natural cave networks. Recognizing that innovative, enhanced technologies could accelerate development of critical lifesaving capabilities, DARPA today announced its newest Grand Challenge: the DARPA Subterranean Challenge, or SubT for short.

https://www.spreaker.com/user/talk4media/beyond-confidence-12-18-2017

Whether or not immortality is possible, whether or not one would like it for oneself, it’s important to keep in mind that it is not what biomedical research against ageing is about.

When doing science, it is crucially important to have clear, unambiguous definitions. These definitions must be firmly established to avoid confusion and misunderstandings and possibly to prevent people from going around telling everyone that you’re working on something that you’re actually not.

The I-word

Continue reading “For the last time: rejuvenation is not immortality” »

Pyongyang is conducting tests to see if anthrax germs can survive at temperatures of 7,000 degrees or more.

Good stuff from Aubrey. One person is a deathist, another is a maybe, the other is pro-life extension.

Turning back the clock and undoing the ravages of time. Something we’ve probably all wondered about — but could it become reality? Or are we all just wishing our lives away?
We may soon be able to stop or even undo the ageing process. By purging the body of so-called ‘retired cells’, scientists say we could look younger, live longer, and defeat disease. Is this science’s answer to the fabled fountain of youth?
At the Roundtable was Aubrey de Grey, Biomedical gerontologist and Chief Science Officer at Sens Research Foundation; Lara Marks, a visiting Research Associate at University College London and Historian of Medicine at King’s College London; Professor Ilaria Bellantuono, Stem cell biologist and Professor in musculoskeletal ageing at the University of Sheffield and journalist Salman Shaheen.
Roundtable is a discussion programme with an edge. Broadcast out of London and presented by David Foster, it’s about bringing people to the table, listening to every opinion, and analysing every point of view. From fierce debate to reflective thinking, Roundtable discussions offer a different perspective on the issues that matter to you. Watch it every weekday at 15:30 GMT on TRT World.

Continue reading “Can we reverse the ageing process?” »

The rise of AI (Artificial Intelligence) robots can be concerning for some people but that’s not stopping them for sure. In fact, there’s a chance that the AI robots will soon have ‘children’ with their owners. Yes, human-robot babies are very much possible, according to a leading artificial intelligence expert.

Dr David Levy, who is the author of Love and Sex with Robots claims that that humans and robots will soon make babies, given the ‘recent progress in stem cell research and artificial chromosomes.’

Though Dr Levy has not given a specific timeline for robot babies, he believes that it could happen within the next 100 years.

Continue reading “Humans and robots can have babies, claims AI expert” »

Biotech is one of today’s many hot frontiers of technology, but one thing holding it back is that it’s significantly less amenable to traditional computing techniques than other areas. A new startup called Asimov, spun off from research at MIT, is working on bridging the gap between the digital and the biological by creating, essentially, a set of computer-aided biology design tools. It’s a prescient enough idea that it has attracted $4.7 million in seed funding.

The problem that Asimov addresses is this. Say you’re a pharmaceutical company trying to make a tiny biocompatible machine that holds a certain amount of medication and releases it when it senses some other molecule.

In order to do so, you’d have to — well, among about a million other things — design what amounts to a logic gate and signal processor that works at the molecular scale. This is a daunting prospect, as creating molecular machinery is a labor-intensive process often involving creating thousands of variations of a given structure and testing them repeatedly to see which works.

Continue reading “Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz” »